R2S Bio Products Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 10 Year, 5 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.87 Cr
- Revenue Growth -98.61%
- Profit Growth -10.28%
- Ebitda -1759.28%
- Net Worth 5.63%
- Total Assets 4.24%
About R2S Bio Products
R2s Bio Products Private Limited (RBPPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 January 2015 and has a history of Ten years. Its registered office is in Rohtak, Haryana, India.
The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company has closed loans amounting to ₹4.87 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Santosh Gondhalekar, Rajesh Date, Ganesh Shirode, and Seven other members serve as directors at the Company.
Company Details
-
Location
Rohtak, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U11100HR2015PTC054441
-
Company No.
054441
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Jan 2015
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at R2S Bio Products?
Board Members (10)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sahil Bansal
|
Director | 04-Sep-2018 | Current |
|
Rajesh Date
|
Additional Director | 22-Jan-2022 | Current |
|
Ganesh Shirode
|
Director | 29-Sep-2020 | Current |
|
Amod Ghamande
|
Additional Director | 30-Mar-2021 | Current |
|
Santosh Gondhalekar
|
Additional Director | 22-Jan-2022 | Current |
|
Meenakshi Gupta
|
Director | 04-Sep-2018 | Current |
Financial Performance of R2S Bio Products.
R2S Bio Products Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 98.61% decrease. The company also saw a substantial fall in profitability, with a 10.28% decrease in profit. The company's net worth moved up by a moderate rise of 5.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of R2S Bio Products?
Unlock access to R2S Bio Products's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Padmavati Ferrous LimitedMeenakshi Gupta is a mutual person
-
Primove Engineering Private LimitedSantosh Gondhalekar is a mutual person
-
Deccan Environmental Consultants Private LimitedAmod Ghamande is a mutual person
-
Gangotree Landmarks LlpSantosh Gondhalekar is a mutual person
-
Gangotree Eco Technologies Private Limited
Santosh Gondhalekar is a mutual person
-
Gangotree Energy Projects Private Limited
Santosh Gondhalekar is a mutual person
Charges (Loans)
₹0
₹4.87 Cr
Charges Breakdown by Lending Institutions
- Others : 4.20 Cr
- Canara Bank : 0.67 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Dec 2015 | Others | ₹2.10 Cr | Satisfied |
| 22 Dec 2015 | Others | ₹2.10 Cr | Satisfied |
| 02 Dec 2015 | Canara Bank | ₹6.70 M | Satisfied |
How Many Employees Work at R2S Bio Products?
Unlock and access historical data on people associated with R2S Bio Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of R2S Bio Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R2S Bio Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
